Entry Detail



General Information

Database ID:exR0359197
RNA Name:AASDHPPT
RNA Type:mRNA
Chromosome:chr11
Starnd:+
Coordinate:
Start Site(bp):106075501End Site(bp):106098699
External Links:ENSG00000149313



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
GTF2F2
chr13
45120510
45284893
+
CFL1
chr11
65823022
65862026
-
NUP93
chr16
56730118
56850286
+
HSD17B8
chr6
33204655
33206831
+
RPL3
chr22
39312882
39320389
-
RASSF3
chr12
64507001
64697564
+
TMBIM6
chr12
49707725
49764934
+
HNRNPL
chr19
38836388
38852347
-
CXXC4
chr4
104468308
104494901
-
PSME3
chr17
42824385
42843760
+
AHCY
chr20
34280268
34311802
-
ESRP1
chr8
94641074
94707466
+
AKAP10
chr17
19904302
19978343
-
PCLAF
chr15
64364304
64387687
-
COA3
chr17
42795147
42798704
-
MTA2
chr11
62593214
62601865
-
EIF4G2
chr11
10797050
10808940
-
WDR73
chr15
84639281
84654343
-
PUM2
chr2
20248691
20352234
-
GTPBP6
chrX
304529
318819
-
NAP1L4
chr11
2944431
2992377
-
MATR3
chr5
139273752
139331671
+
IRF7
chr11
612553
615983
-
SINHCAF
chr12
31280584
31327058
-
RAB8A
chr19
16111889
16134234
+
SPG21
chr15
64963022
64990310
-
PANK3
chr5
168548495
168579368
-
DIAPH1
chr5
141515016
141619055
-
RPS29
chr14
49570984
49599164
-
HMGA1
chr6
34236873
34246231
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC064807.1
chr8
51899268
51949874
+
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.